In Vitro Diagnostics Biocartis SA Series C generates €71mm for Biocartis Four-year-old Swiss molecular diagnostics company Biocartis NV has raised €71mm ($96mm) in its Series C financing led by
In Vitro Diagnostics LipoFit Analytic GMBH LipoFit Analytic brings in €4mm through early round Dec. — LipoFit Analytic GMBH (diagnostics) has raised €4mm ($5.7mm) through its latest venture round.
Mergers & Acquisitions Acclarent Inc. & Ethicon Inc. (a division of Johnson & Johnson) Johnson & Johnson 's Ethicon has acquired closely held Acclarent , a company developing minimally invasive